AN ECONOMIC PRICE ANALYSIS OF CONVENTIONAL REMISSION THERAPY VS BIOLOGICAL THERAPY FOR RHEUMATOID ARTHRITIS TREATMENT
Rheumatoid arthritis represents the most common inflammatory rheumatism, affecting about 1% of the general population. Inappropriately untreated usually has a progressively aggressive perspective, generating pain and joint inflammation and functional disability. The severity of the disease resul...
Saved in:
| Main Authors: | Mihaela-Simona SUBTIRELU, Adina TURCU-STIOLICA, Florentin-Ananu VREJU, Johny NEAMTU |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Universitaria Press Craiova
2019-05-01
|
| Series: | Management & Marketing |
| Subjects: | |
| Online Access: | http://mnmk.ro/en/documents/2019_1/3-10-2-19.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
THE STUDY ON THE MEDICAL ADHERENCE OF PATIENTS TO RHEUMATOID ARTHRITIS TREATMENT
by: Mihaela-Simona SUBTIRELU, et al.
Published: (2018-05-01) -
RHEUMATOID ARTHRITIS: THE PROBLEMS OF REMISSION AND THERAPY RESISTANCE
by: E. L. Nasonov, et al.
Published: (2018-07-01) -
ADALIMUMAB DISCONTINUATION IN PATIENTS WITH RHEUMATOID ARTHRITIS AFTER ACHIEVING SUSTAINED REMISSION
by: N. V. Demidova, et al.
Published: (2018-07-01) -
Disease remission and sustained remission after etanercept biosimilar or originator initiation in rheumatoid arthritis: an interim real-world analysis
by: Marina G. Birck, et al.
Published: (2025-07-01) -
Are the goals of therapy achievable in patients with rheumatoid arthritis receiving upadacitinib in real clinical practice?
by: V. N. Amirjanova, et al.
Published: (2022-07-01)